Log In
BCIQ
Print this Print this
 

rimeporide

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionSolute carrier family 9 sodium hydrogen exchanger member 1 (SLC9A1; NHE1) inhibitor
Molecular Target Solute carrier family 9 sodium hydrogen exchanger member 1 (SLC9A1) (NHE1)
Mechanism of ActionSolute carrier family 9 sodium hydrogen exchange member 1 (SLC9A1) (NHE1) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today